⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6123494 | 0.97 | HTT (0.45) | — | |
| SCHEMBL637498 | 0.97 | HTT (0.45) | — | |
| SCHEMBL19052251 | 0.94 | — | — | |
| SCHEMBL29107984 | 0.92 | CA2 (0.41) | — | |
| SCHEMBL9613513 | 0.88 | — | — | |
| SCHEMBL8033657 | 0.85 | HTT (0.50) | — | |
| Trifluoroacetic Acid SCHEMBL6218638 | 0.85 | HTT (0.38) | — | |
| SCHEMBL14500231 | 0.82 | CA12 (0.53) | — | |
| SCHEMBL4685447 | 0.80 | HTT (0.31) | — | |
| SCHEMBL10155509 | 0.79 | CA12 (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124489-A1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2024-04-18 | — | — | US | claimed |
| CN-115785070-B | Pyrrolidinyl acetamide derivative, preparation method and application thereof | 桂林医学院附属医院 | 2023-06-09 | — | — | CN | claimed |
| CN-114761404-A | Substituted bicyclic heteroaryl compounds | 百时美施贵宝公司 | 2022-07-15 | — | — | CN | claimed |
| US-20210121397-A1 | BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS | ALLERGAN INC (US) | 2021-04-29 | — | — | US | claimed |
| WO-2021067326-A1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-04-08 | — | — | WO | claimed |
| US-10881608-B2 | Biodegradable intravitreal tyrosine kinase implants | ALLERGAN, INC. (US) | 2021-01-05 | — | — | US | claimed |
| CN-109923114-A | Pyrazolopyridine derivatives as HPK1 modulators and their use for the treatment of cancer | 因赛特公司 | 2019-06-21 | — | — | CN | claimed |
| EP-3008055-B1 | TETRAZOLONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2017-07-19 | — | — | EP | claimed |
| EP-3008055-A1 | NOVEL TETRAZOLONE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2016-04-20 | — | — | EP | claimed |
| US-20160083357-A1 | NOVEL TETRAZOLONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2016-03-24 | — | — | US | claimed |
| WO-2014198592-A1 | NOVEL TETRAZOLONE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2014-12-18 | — | — | WO | claimed |
| US-20120301426-A1 | ALKANOYLAMINO BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-11-29 | — | — | US | claimed |
| EP-2432784-A1 | FUSED BICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB Pharma, S.A. (BE) | 2012-03-28 | — | — | EP | claimed |
| US-20100310500-A1 | ALKANOYLAMINO BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-12-09 | — | — | US | claimed |
| WO-2010133836-A1 | FUSED BICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA S.A. (BE) | 2010-11-25 | — | — | WO | claimed |
| US-20070249847-A1 | Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof | TEIJIN PHARMA LIMITED (JP) | 2007-10-25 | — | — | US | claimed |
| EP-1760075-A1 | METHOD FOR PRODUCING ACETAMIDOPYRROLIDINE DERIVATIVE AND INTERMEDIATE COMPOUND THEREOF | Teijin Pharma Limited (JP) | 2007-03-07 | — | — | EP | claimed |
| CN-1085893-A | Process for preparing pyrrolidinylacetamide derivatives | DAIICHI SEIYAKU CO (JP) | 1994-04-27 | — | — | CN | claimed |
| JP-51133287-A | — | — | None | — | — | JP | disclosed |
| JP-S51133287-A | A PROCESS FOR PREPARING QUINAZOLONEACETIC ACID AMIDE DERIVATIVES | TANABE SEIYAKU CO LTD | 1976-11-18 | — | — | JP | disclosed |